Photogallery

Longevity is no longer just a healthcare issue, but a strategic factor reshaping business models, investments and public policies. Increasing life expectancy, combined with accelerating technological progress, is transforming the way companies develop products and services throughout people’s entire life journey.

In this context, AgeTech – digital technologies, innovative devices and solutions for personalized health and well-being – is becoming a key sector in supporting active ageing and promoting prevention, creating new opportunities for economic growth and innovation.

The talk will explore how life sciences, pharmaceuticals, biotechnology and AgeTech are converging to transform prevention and well-being into key drivers of the Longevity Economy. It will examine the role of businesses, the impact of public policies and the potential of transatlantic collaboration between Italy and the United States in shaping the future of longevity.